Expression of programmed death-ligand 1 and programmed death-1 in patients with extramammary paget's disease
Background: Extramammary Paget's disease (EMPD) is a rare skin cancer and sometimes has fatal prognosis. For progressive cases, therapeutic options are limited. In recent years, treatment with an anti-programmed death-1 (PD-1) antibody has improved the prognosis of various malignancies. In addi...
Main Authors: | Hiroyuki Goto, Kazunari Sugita, Osamu Yamamoto |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | Indian Journal of Dermatology |
Subjects: | |
Online Access: | http://www.e-ijd.org/article.asp?issn=0019-5154;year=2021;volume=66;issue=2;spage=169;epage=173;aulast=Goto |
Similar Items
-
Extramammary Paget′s disease in two brothers
by: Xiaoting Zhang, et al.
Published: (2015-01-01) -
Expression of PD-1 and PD-L1 in Extramammary Paget Disease: Implications for Immune-Targeted Therapy
by: Shakuntala H. Mauzo, et al.
Published: (2019-05-01) -
Expression of programmed death-ligand 1 in cutaneous squamous cell carcinoma arising in sun-exposed and nonsun-exposed skin
by: Hiroyuki Goto, et al.
Published: (2020-01-01) -
A Case Report of Familial Extramammary Paget's Disease in Female Siblings
by: Thanachat Rutnumnoi, et al.
Published: (2021-03-01) -
The Outcome of Chemotherapy for Metastatic Extramammary Paget’s Disease
by: Hiroki Hashimoto, et al.
Published: (2021-02-01)